Cytomegalovirus (CMV): Research
- CMV Vector Vaccination Leads to Apparent Clearance of SIV Infection (March 25, 2013)
Selected research highlight from CROI 2013.
In Michael Palm HIV Basic Science, Vaccines & Prevention Project Weblog, from Treatment Action Group
On TheBodyPRO.com
- Does CMV Underlie the Increased Risk of Cardiovascular Disease in Patients With HIV? (April 16, 2012)
From aidsmap.com
- Experimental Vaccine Shows Promise in Preventing Cytomegalovirus Infection (March 19, 2009)
From U.S. National Institute of Allergy and Infectious Diseases
On TheBodyPRO.com
- Cytomegalovirus Retinitis: The Neglected Disease of the AIDS Pandemic (December 1, 2007)
In PLoS Medicine
- Cytomegalovirus Viremia, Mortality, and End-Organ Disease Among Patients With AIDS Receiving Potent Antiretroviral Therapies (April 15, 2005)
In Journal of Acquired Immune Deficiency Syndromes
- CMV Levels May Predict HIV Disease Progression (October 2004)
Quick recap of a study in The Lancet.
In HIV Treatment ALERTS!, from The Center for AIDS
- CMV-Related Disease: The Pros and Cons of HAART (October 2003)
In HIV Treatment ALERTS!, from The Center for AIDS
- HAART Good for Vision and Quality of Life, Studies Find (June 18, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
- A Synergistic Effect of HIV and CMV Infection/Reactivation on Response to HAART and Plasma CD8+/CD38+ But Not CD4+ Cell Populations in Patients With Primary HIV Infection (July 10, 2002)
In The XIV International AIDS Conference, from TheBodyPRO.com
- Oral Valganciclovir as Effective as IV Ganciclovir in Treating CMV Retinitis in AIDS Patients (April 12, 2002)
Results of a recent Emory University study.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
- Discontinuation of Maintenance Therapy for Cytomegalovirus Retinitis in HIV-Infected Patients Who Have Responded to Highly Active Antiretroviral Therapy (December 18, 2001)
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from TheBodyPRO.com
- Needleless Retinitis Therapy with FDA Approval of Oral CMV Drug (April 2001)
In TAGline, from Treatment Action Group
On TheBodyPRO.com
- Advances in Treating CMV (August 2000)
In Project Inform Perspective, from Project Inform
- Long-Term Effects of HAART on Morbidity and Mortality in HIV-1-Infected Patients at Risk for CMV Disease (January 31, 2000)
In The 7th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Multicenter Evaluation of CMV Reactivation in HIV-infected Women at Potential Risk for CMV Disease (January 31, 2000)
In The 7th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Anti-HIV Treatment Improves Immune System and Fights Sight-Threatening Eye Infection (November 2, 1999)
From U.S. National Institutes of Health
On TheBodyPRO.com
- Update: Treatment of CMV Retinitis (October 1999)
In HIV Newsline, from San Francisco General Hospital
- A New Acronym, a New Threat: IRU (September 1999)
In Project Inform Perspective, from Project Inform
- Secondary Prophylaxis for CMV Retinitis (August 1999)
In HIV Newsline, from San Francisco General Hospital
- Cytomegalovirus Infection and HIV-1 Disease Progression in Infants Born to HIV-1?Infected Women (July 8, 1999)
In New England Journal of Medicine
- HIV-Related Clinical Updates: CMV/Cytomegalovirus Disease (May 2, 1998)
In The 8th Clinical Care Options for HIV Symposium, from TheBodyPRO.com
|
Advertisement
|
Email
Glossary
